| Market Capitalization (Millions $) |
244 |
| Shares
Outstanding (Millions) |
70 |
| Employees |
500 |
| Revenues (TTM) (Millions $) |
112 |
| Net Income (TTM) (Millions $) |
-49 |
| Cash Flow (TTM) (Millions $) |
-71 |
| Capital Exp. (TTM) (Millions $) |
7 |
Business Description
Orasure Technologies Inc. is a public health diagnostic company that specializes in the development, manufacture, and distribution of oral fluid collection devices, diagnostic kits, and platform technologies. The company, which is headquartered in Bethlehem, Pennsylvania, was founded in 2000, and it primarily focuses on developing innovative medical solutions for HIV, hepatitis C, and other infectious diseases.
Orasure Technologies has developed a range of products that are marketed in more than 100 countries worldwide. Its flagship product is the OraQuick HIV, which is the first FDA-approved and CLIA waived rapid oral fluid test for HIV-1 and HIV-2. OraQuick is very easy to use, and it provides accurate results within 20 minutes, making it an important tool for public health screening programs.
In addition to OraQuick, Orasure Technologies has developed a portfolio of other health diagnostic products. These include OraSure, an oral specimen collection device used for testing hepatitis C; Intercept, a collection device used for oral fluid drug screening; and GenoSure PRIME, a genetic sequencing test used for HIV viral load monitoring.
One of the significant achievements of Orasure Technologies is its collaboration with the Centers for Disease Control and Prevention (CDC) to develop the first at-home HIV testing kit named "OraQuick In-Home HIV Test." The kit is marketed directly to the general public and provides an accessible home testing option, helping people control their HIV status and make informed decisions about their health.
Orasure Technologies has been recognized for its innovative technologies and outstanding business practices. It has been awarded numerous patents for its products and has been listed among the top 25 innovative companies by the Technology Fast 500 list in 2015.
In summary, Orasure Technologies Inc is a global industry leader in the public health diagnostic field, with products that are making a tremendous impact on combating the spread of infectious diseases such as HIV and hepatitis. The company has demonstrated a commitment to innovation and its corporate values of reliability, innovation, and excellence in serving its customers.
Company Address: 220 East First Street Bethlehem 18015 PA
Company Phone Number: 882-1820 Stock Exchange / Ticker: NASDAQ OSUR
|
6.03% 
183.1 %